MENU
CAH
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Cardinal Health (CAH) Ownership - Who owns Cardinal Health?

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers... Show more

A.I.Advisor
Nov 03, 2026

What Is Cardinal Health (CAH)? Company Overview, Business Model and Market Position

Key Takeaways

  • Cardinal Health, Inc. (CAH) is a global healthcare services and products company headquartered in Dublin, Ohio.
  • The company operates two main reportable segments: Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD), alongside growth businesses in nuclear medicine, at-home solutions, and logistics.
  • Cardinal Health is one of the largest pharmaceutical distributors in the United States, serving hospitals, pharmacies, and healthcare providers.
  • The company generates most of its revenue from pharmaceutical distribution, a high-volume, relatively low-margin business.
  • Cardinal Health competes primarily with other major drug distributors such as MCK (McKesson) and COR (Cencora).

Introduction

Cardinal Health, Inc. is a diversified healthcare services and products company that operates at the center of the medical supply chain. It connects pharmaceutical manufacturers, healthcare providers, pharmacies, and patients, handling the distribution of medicines and the manufacture of medical products used in hospitals, clinics, and homes. Because healthcare spending is broadly non-discretionary, investors often view Cardinal Health's company overview as a way to gain exposure to steady, recurring demand across the healthcare system. The stock trades on the New York Stock Exchange under the ticker CAH.

Company Profile and Business Model

Cardinal Health traces its roots to 1971, when founder Robert D. Walter began building a food wholesaling business that later pivoted toward healthcare distribution. The company was incorporated in 1979 and is today headquartered in Dublin, Ohio. Over the decades, it grew through a combination of organic expansion and acquisitions to become one of the largest players in the U.S. pharmaceutical distribution market.

The company's business model centers on the efficient movement of pharmaceuticals and medical products at enormous scale. Its Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter (OTC) healthcare and consumer products, primarily in the United States. This segment is the company's largest revenue driver and also includes specialty pharmacy services, manufacturer services, and a nuclear pharmacy network.

The Global Medical Products and Distribution (GMPD) segment manufactures, sources, and distributes Cardinal Health–branded medical, surgical, and laboratory products. These include exam and surgical gloves, needles and syringes, surgical drapes and gowns, fluid suction and collection systems, and wound care and urology products. These products are sold in the United States, Canada, Europe, Asia, and other international markets.

Beyond these two reportable segments, Cardinal Health operates several growth businesses grouped under "Other," including nuclear and precision health solutions (radiopharmaceuticals), at-home solutions (direct-to-patient medical supplies), and OptiFreight Logistics (freight management for healthcare). This diversification broadens the company's financial profile beyond traditional distribution.

How Cardinal Health Makes Money

Cardinal Health's primary revenue source is pharmaceutical distribution, which typically accounts for the vast majority of total sales. This is a high-volume business characterized by thin profit margins, because the company acts largely as an intermediary between drug manufacturers and the pharmacies, hospitals, and other providers that dispense medications. Profitability therefore depends on scale, supply-chain efficiency, and value-added services such as specialty logistics and manufacturer programs.

The medical products segment and the growth businesses generally carry higher margins than core pharmaceutical distribution. Because healthcare demand tends to be resilient across economic cycles, Cardinal Health's market position provides relatively stable revenue, even though pricing pressure and regulatory changes can affect profitability from year to year.

Why Investors Follow CAH

Investors follow Cardinal Health for several reasons. First, the company operates in a structurally growing market driven by an aging population, rising demand for specialty and chronic-disease medications, and increasing utilization of healthcare services. Second, its scale and distribution network create significant barriers to entry, while its relationships with both manufacturers and providers give it a central role in the supply chain.

Cardinal Health has also expanded into higher-growth areas such as specialty pharmaceuticals, nuclear medicine, and at-home care, which management views as avenues for improved margins and diversification. The company pays a quarterly dividend and has used share repurchases as part of its capital-allocation strategy, which can appeal to income-oriented and long-term investors. As one of the "big three" U.S. drug distributors alongside McKesson and Cencora, Cardinal Health's performance is closely watched as a barometer of pharmaceutical market activity.

Risks and Important Considerations

Investors should be aware of several risks. Pharmaceutical distribution is a low-margin business sensitive to drug pricing, generic-drug deflation, and reimbursement changes, including government pricing policies. Customer concentration is notable, as the loss of a major pharmacy or health-system contract can meaningfully affect revenue.

The company also faces regulatory and legal exposure, including historical litigation and settlements related to the distribution of opioid medications. Operational risks include supply-chain disruptions, tariffs on imported medical products, and inflation in labor and transportation costs. Finally, competition from McKesson, Cencora, and other distributors remains intense, and technological or market changes could pressure the traditional distribution model over time.

AI Screener

For investors seeking to identify opportunities across stocks and ETFs, Tickeron's AI Screener is an AI-powered discovery platform that helps traders and investors filter thousands of securities using technical indicators, fundamentals, volatility, trends, AI-generated signals, industries, and price patterns. Its customizable filters make it possible to narrow the universe to ideas that match a specific investment strategy. Explore the AI Screener to streamline your research and uncover opportunities that fit your approach.

Conclusion

Cardinal Health is a foundational player in the U.S. healthcare supply chain, distinguished by its scale in pharmaceutical distribution and its expanding portfolio of medical products and higher-growth services. Its central role in connecting manufacturers, providers, and patients gives it a durable market position, even as thin margins and regulatory dynamics shape its financial results. For investors, CAH offers exposure to the broad, resilient demand for healthcare products and services, balanced by the risks inherent in a large-scale, tightly regulated distribution business.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Profile

Industry
Medical Distributors
Address
7000 Cardinal Place
Phone
+1 614 757-5000
Employees
63900
Web
https://www.cardinalhealth.com

Details

Group
Domestic Stock Funds
Category
Distribution Services
Capitalization
62.92B
P/E Ratio
37.38
Total Cash
4.86B
Projected Growth
1.10
Total Debt
8.89B
Revenue
254.25B
Risk (Beta)
0.29
Dividend Yield
0.01
Total Cash/Share
20.97
Total Debt/Equity
60.01
Revenue/Share
1072.78 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a maker of pharmaceuticals, medical, surgical and laboratory supplies as well as develops drug delivery systems

Industry MedicalDistributors

Industry
Medical Distributors
Address
7000 Cardinal Place
Phone
+1 614 757-5000
Employees
63900
Web
https://www.cardinalhealth.com
Who owns Cardinal Health? CAH symbol Ownership - Tickeron.com